Printed meds accelerate clinical testing sans toxic solvents
A new technique for printing medications without using solvents can accelerate drug screening and clinical testing, say researchers.
Archives for October 5, 2017
Synthon's generic version of Copaxone 40mg approved in Europe
European regulators have approved a generic 40mg version of Teva Pharmaceutical Industries’ multiple sclerosis drug Copaxone (glatiramer acetate).
News In Brief
Tubilux gets on track & TraceLink
CMO Tubilux Pharma has selected TraceLink to manage its supply chain security.
Gilead hands rights to make HIV drug candidate to firms in developing countries
Gilead Sciences Inc. has licensed production rights to its candidate HIV drug bictegravir to the Medicines Patent Pool (MPP).
With $150m in its pocket, new cancer startup will turn to CROs to ‘execute faster’
Cullinan Oncology has launched with $150m in funding, a focus on risk, and a business model through which it will rely on a global network of third-party vendors, says CEO.
Pharma focused digital comms agency ramarketing secures funding for US office
CMO PR agency ramarketing has secured investment to set up a US base in a bid to attract North American contractors interested in accessing the complex European market.